5 Lessons from Harvard Pilgrim’s ICD-10 Implementation

As the October deadline for switching to ICD-10 comes ever closer, health care organizations are looking to their peers and to their payor partners for real-world practical advice. Harvard Pilgrim Health Care, health benefits company serving primarily members in Massachusetts, New Hampshire and Maine, shared its lessons learned from ICD-10 implementation at the Massachusetts Health Data Consortium’s March 10 conference on ICD-10 planning.

Among the challenges and lessons Harvard Pilgrim learned were:

  1. Gain ongoing support from leadership early on.
  2. Engage business stakeholders early and involve them in planning and implementation.
  3. Manage key dependencies to decrease their impact on the timeline.
  4. Understand how data should drive implementation strategies, but don't assume ICD-10 implementation is just an IT issue.
  5. Tightly manage the change control process. “We didn’t make it easy for people to change dates. That was not popular, but it worked,” Hunt noted.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.